{
  "trial_id": "NCT02413320",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, ECOG Performance Status, hormone receptor status, HER-2 status, tumor stage, leukocyte count, absolute neutrophil count, platelet count, total bilirubin, AST(SGOT)/ALT(SPGT) levels, creatinine levels, creatinine clearance, serum albumin, left ventricular ejection fraction (LVEF), breast and axillary imaging results, presence of clinically/radiologically abnormal axillary lymph nodes, neuropathy grade, history of allergic reactions to study compounds, presence of uncontrolled intercurrent illness, pregnancy/nursing status, history of concomitant or previous malignancies, cardiac function status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Lymph node status",
          "presence of clinically/radiologically abnormal axillary lymph nodes"
        ],
        [
          "T stage",
          "tumor stage"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "hormone receptor status",
        "HER-2 status",
        "leukocyte count",
        "absolute neutrophil count",
        "platelet count",
        "total bilirubin",
        "AST(SGOT)/ALT(SPGT) levels",
        "creatinine levels",
        "creatinine clearance",
        "serum albumin",
        "left ventricular ejection fraction (LVEF)",
        "breast and axillary imaging results",
        "neuropathy grade",
        "history of allergic reactions to study compounds",
        "presence of uncontrolled intercurrent illness",
        "pregnancy/nursing status",
        "history of concomitant or previous malignancies",
        "cardiac function status"
      ]
    },
    "processed-gen-response": "Age, sex, ECOG Performance Status, hormone receptor status, HER-2 status, tumor stage, leukocyte count, absolute neutrophil count, platelet count, total bilirubin, AST(SGOT)/ALT(SPGT) levels, creatinine levels, creatinine clearance, serum albumin, left ventricular ejection fraction (LVEF), breast and axillary imaging results, presence of clinically/radiologically abnormal axillary lymph nodes, neuropathy grade, history of allergic reactions to study compounds, presence of uncontrolled intercurrent illness, pregnancy/nursing status, history of concomitant or previous malignancies, cardiac function status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Tumor Stage, Hormone Receptor Status, HER-2 Status, Leukocyte Count, Absolute Neutrophil Count, Platelet Count, Total Bilirubin, AST(SGOT)/ALT(SPGT) Levels, Creatinine Levels, Creatinine Clearance, Serum Albumin, Left Ventricular Ejection Fraction (LVEF), Breast and Axillary Imaging Results, Pathological Confirmation of Disease,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Lymph node status",
        "T stage"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "ECOG Performance Status",
        "Tumor Stage",
        "Hormone Receptor Status",
        "HER-2 Status",
        "Leukocyte Count",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Total Bilirubin",
        "AST(SGOT)/ALT(SPGT) Levels",
        "Creatinine Levels",
        "Creatinine Clearance",
        "Serum Albumin",
        "Left Ventricular Ejection Fraction (LVEF)",
        "Breast and Axillary Imaging Results",
        "Pathological Confirmation of Disease"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Tumor Stage, Hormone Receptor Status, HER-2 Status, Leukocyte Count, Absolute Neutrophil Count, Platelet Count, Total Bilirubin, AST(SGOT)/ALT(SPGT) Levels, Creatinine Levels, Creatinine Clearance, Serum Albumin, Left Ventricular Ejection Fraction (LVEF), Breast and Axillary Imaging Results, Pathological Confirmation of Disease"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Menopausal Status, Body Mass Index, ECOG Performance Status, Tumor Stage, Tumor Size, Lymph Node Status, Estrogen Receptor Status, Progesterone Receptor Status, HER2 Status, Ki-67 Status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Lymph node status",
          "Lymph Node Status"
        ],
        [
          "T stage",
          "Tumor Stage"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "Menopausal Status",
        "Body Mass Index",
        "ECOG Performance Status",
        "Tumor Size",
        "Estrogen Receptor Status",
        "Progesterone Receptor Status",
        "HER2 Status",
        "Ki-67 Status"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Menopausal Status, Body Mass Index, ECOG Performance Status, Tumor Stage, Tumor Size, Lymph Node Status, Estrogen Receptor Status, Progesterone Receptor Status, HER2 Status, Ki-67 Status."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, ECOG Performance Status, tumor stage, tumor size, hormone receptor status, HER-2 status, menopausal status, prior breast cancer, prior chemotherapy, prior radiation therapy, prior hormone therapy, LVEF, serum albumin, creatinine clearance, AST, ALT, total bilirubin, leukocytes, absolute neutrophil count, platelets.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "menopausal status"
        ],
        [
          "Lymph node status",
          "tumor stage"
        ],
        [
          "T stage",
          "tumor size"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "ECOG Performance Status",
        "hormone receptor status",
        "HER-2 status",
        "prior breast cancer",
        "prior chemotherapy",
        "prior radiation therapy",
        "prior hormone therapy",
        "LVEF",
        "serum albumin",
        "creatinine clearance",
        "AST",
        "ALT",
        "total bilirubin",
        "leukocytes",
        "absolute neutrophil count",
        "platelets"
      ]
    },
    "processed-gen-response": "Age, race, ethnicity, ECOG Performance Status, tumor stage, tumor size, hormone receptor status, HER-2 status, menopausal status, prior breast cancer, prior chemotherapy, prior radiation therapy, prior hormone therapy, LVEF, serum albumin, creatinine clearance, AST, ALT, total bilirubin, leukocytes, absolute neutrophil count, platelets."
  }
}